Related Experiment Video
Updated: May 29, 2026
06:02
Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants
Published on: November 28, 2025
Progressive multifocal leukoencephalopathy: clinical and molecular aspects.
Eleonora Tavazzi1, Martyn K White, Kamel Khalili
1Department of Neuroscience, Center for Neurovirology, Temple University School of Medicine, Philadelphia, PA, USA.
Reviews in Medical Virology
|September 22, 2011
Summary
Progressive multifocal leukoencephalopathy (PML), a rare fatal brain disease, is linked to immune dysfunction and the widespread JC polyomavirus (JCV). Understanding JCV
Area of Science:
- Neuroimmunology
- Viral Pathogenesis
- Molecular Virology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, fatal demyelinating disease of the central nervous system (CNS).
- PML is strongly associated with immune dysfunction, including HIV/AIDS and side effects of immunomodulatory therapies.
- The etiological agent, JC polyomavirus (JCV), is globally prevalent, contrasting with the rarity of PML.
Purpose of the Study:
- To review the current understanding of clinical features of PML.
- To discuss the molecular characteristics of JCV.
- To explore the relationship between clinical PML manifestations and JCV molecular biology for therapeutic insights.
Main Methods:
- Review of existing laboratory and clinical observations on JCV and PML.
- Synthesis of data on viral life cycle and disease pathogenesis.
- Correlation of clinical findings with molecular virology studies.
Main Results:
- JCV is widespread, but PML is rare, highlighting the critical role of immune status.
- Significant progress has been made in understanding JCV and PML over 40 years.
- Key aspects of JCV's life cycle and PML pathogenesis remain incompletely understood.
Conclusions:
- Clinical observations of PML can guide molecular investigations of JCV.
- Molecular insights into JCV can inform the development of novel therapeutic strategies for PML.
- An integrated approach combining clinical and molecular data is crucial for advancing PML research.
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...